• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼皮肤白化病的分子遗传学

Molecular genetics of oculocutaneous albinism.

作者信息

Spritz R A

机构信息

Department of Medical Genetics, University of Wisconsin, Madison 53706.

出版信息

Semin Dermatol. 1993 Sep;12(3):167-72.

PMID:8217557
Abstract

Oculocutaneous albinism (OCA) is a group of autosomal recessive disorders characterized by deficient synthesis of melanin pigment. Type I (tyrosinase-deficient) OCA results from deficient enzymatic activity of tyrosinase, which catalyzes at least three steps in the melanin biosynthetic pathway. Type II (tyrosinase-positive) OCA results from abnormalities of the "P" polypeptide. Recent application of molecular genetic techniques to the study of these disorders has led to extraordinary advances in knowledge of their molecular pathogenesis, paving the way to improved diagnosis, carrier detection, and even treatment.

摘要

眼皮肤白化病(OCA)是一组常染色体隐性疾病,其特征为黑色素合成不足。I型(酪氨酸酶缺乏型)OCA是由于酪氨酸酶的酶活性不足所致,酪氨酸酶在黑色素生物合成途径中催化至少三个步骤。II型(酪氨酸酶阳性型)OCA是由“P”多肽异常引起的。最近将分子遗传学技术应用于这些疾病的研究,在其分子发病机制的认识上取得了非凡进展,为改进诊断、携带者检测乃至治疗铺平了道路。

相似文献

1
Molecular genetics of oculocutaneous albinism.眼皮肤白化病的分子遗传学
Semin Dermatol. 1993 Sep;12(3):167-72.
2
Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.I型(酪氨酸酶缺乏型)眼皮肤白化病中的酪氨酸酶基因突变定义了两个错义替换簇。
Am J Med Genet. 1992 Jul 15;43(5):865-71. doi: 10.1002/ajmg.1320430523.
3
Molecular genetics of oculocutaneous albinism.眼皮肤白化病的分子遗传学
Hum Mol Genet. 1994;3 Spec No:1469-75. doi: 10.1093/hmg/3.suppl_1.1469.
4
[Human oculocutaneous albinism. From clinical observation to molecular biology].[人类眼皮肤白化病。从临床观察到分子生物学]
Bull Soc Pathol Exot. 1993;86(5):313-26.
5
OCA1 in different ethnic groups of india is primarily due to founder mutations in the tyrosinase gene.印度不同种族中的OCA1主要是由于酪氨酸酶基因中的奠基者突变。
Ann Hum Genet. 2006 Sep;70(Pt 5):623-30. doi: 10.1111/j.1469-1809.2006.00247.x.
6
Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.I型(酪氨酸酶相关)眼皮肤白化病的分子基础:人类酪氨酸酶基因的突变与多态性
Hum Mutat. 1993;2(1):1-6. doi: 10.1002/humu.1380020102.
7
A tyrosinase gene missense mutation in temperature-sensitive type I oculocutaneous albinism. A human homologue to the Siamese cat and the Himalayan mouse.温度敏感型I型眼皮肤白化病中的酪氨酸酶基因错义突变。一种与暹罗猫和喜马拉雅小鼠同源的人类基因。
J Clin Invest. 1991 Mar;87(3):1119-22. doi: 10.1172/JCI115075.
8
Mutations of the tyrosinase gene in three Korean patients with type I oculocutaneous albinism.三名韩国I型眼皮肤白化病患者酪氨酸酶基因的突变
Jpn J Hum Genet. 1996 Sep;41(3):299-305. doi: 10.1007/BF01913172.
9
Mutations of the tyrosinase gene in Indo-Pakistani patients with type I (tyrosinase-deficient) oculocutaneous albinism (OCA).印度 - 巴基斯坦I型(酪氨酸酶缺乏型)眼皮肤白化病(OCA)患者酪氨酸酶基因的突变
Am J Hum Genet. 1993 Dec;53(6):1173-9.
10
Higher prevalence of OCA1 in an ethnic group of eastern India is due to a founder mutation in the tyrosinase gene.印度东部一个族群中OCA1的高患病率是由于酪氨酸酶基因中的一个奠基者突变。
Mol Vis. 2005 Jul 19;11:531-4.

引用本文的文献

1
[Clinical and molecular genetic analysis of Angelman syndrome with oculocutaneous albinism type 2: A case report and literature review].[伴有2型眼皮肤白化病的安吉尔曼综合征的临床与分子遗传学分析:1例报告及文献复习]
Beijing Da Xue Xue Bao Yi Xue Ban. 2023 Feb 18;55(1):181-185. doi: 10.19723/j.issn.1671-167X.2023.01.028.
2
Tyrosinase gene mutations in the Chinese Han population with OCA1.中国汉族人群中患眼皮肤白化病1型(OCA1)的酪氨酸酶基因突变情况
Genet Res (Camb). 2014 Nov 12;96:e14. doi: 10.1017/S0016672314000160.
3
Molecular genetic studies and delineation of the oculocutaneous albinism phenotype in the Pakistani population.
在巴基斯坦人群中进行分子遗传学研究和眼皮肤白化病表型的描绘。
Orphanet J Rare Dis. 2012 Jun 26;7:44. doi: 10.1186/1750-1172-7-44.
4
Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism.尼替西农可改善白化病皮肤眼模型小鼠的眼部和皮肤色素沉着缺陷。
J Clin Invest. 2011 Oct;121(10):3914-23. doi: 10.1172/JCI59372.
5
Spectrum of candidate gene mutations associated with Indian familial oculocutaneous and ocular albinism.与印度家族性眼皮肤白化病和眼白化病相关的候选基因突变谱。
Mol Vis. 2010 Aug 9;16:1514-24.
6
Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.眼皮肤白化病1型(OCA1)中的酪氨酸酶基因突变:表型的定义
Hum Genet. 2003 Nov;113(6):502-13. doi: 10.1007/s00439-003-0998-1. Epub 2003 Sep 10.
7
Albinism: modern molecular diagnosis.白化病:现代分子诊断
Br J Ophthalmol. 1998 Feb;82(2):189-95. doi: 10.1136/bjo.82.2.189.
8
Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel.以色列不同种族的眼皮肤白化病患者中酪氨酸酶基因的突变
Am J Hum Genet. 1994 Apr;54(4):586-94.
9
Mutations of the tyrosinase gene in Indo-Pakistani patients with type I (tyrosinase-deficient) oculocutaneous albinism (OCA).印度 - 巴基斯坦I型(酪氨酸酶缺乏型)眼皮肤白化病(OCA)患者酪氨酸酶基因的突变
Am J Hum Genet. 1993 Dec;53(6):1173-9.
10
An intragenic deletion of the P gene is the common mutation causing tyrosinase-positive oculocutaneous albinism in southern African Negroids.P基因的基因内缺失是导致南部非洲黑人酪氨酸酶阳性眼皮肤白化病的常见突变。
Am J Hum Genet. 1995 Mar;56(3):586-91.